RecruitingNCT07820644

A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease)

A Single-center, Open-label, Single-arm, Observational Cohort Study on Early Diagnosis and Risk Prediction of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Based on a Digital Management Platform

Sponsor

Cai Qingxian

Enrollment

15,000 participants

Start Date

Jun 1, 2026

Study Type

OBSERVATIONAL

Conditions

Liver Cancer (Primary and Metastatic)

Summary

Evaluating the effectiveness of standardized HCC risk stratification management in improving early diagnosis rates in patients with chronic liver disease

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with liver cancer (primary and metastatic). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

The Third People's Hospital of Shenzhen

Shenzhen, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07820644

Related Trials

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

NCT07636148

Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

NCT074593091 location

Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment

NCT075872161 location

Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy

NCT074454121 location

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

NCT074106761 location